Oracle Investment Management Inc - Net Worth and Insider Trading

Oracle Investment Management Inc Net Worth

The estimated net worth of Oracle Investment Management Inc is at least $0 dollars as of 2024-09-20. Oracle Investment Management Inc is the 10% Owner of Accelerated Pharma Inc and owns about 34,743 shares of Accelerated Pharma Inc (ACCP) stock worth over $0. Details can be seen in Oracle Investment Management Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Oracle Investment Management Inc has not made any transactions after 2007-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Oracle Investment Management Inc

To

Oracle Investment Management Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Oracle Investment Management Inc owns 5 companies in total, including Soleno Therapeutics Inc (SLNO) , Biolase Inc (BIOL) , and Aspira Womens Health Inc (AWH) among others .

Click here to see the complete history of Oracle Investment Management Inc’s form 4 insider trades.

Insider Ownership Summary of Oracle Investment Management Inc

Ticker Comapny Transaction Date Type of Owner
SLNO Soleno Therapeutics Inc 2017-12-15 10 percent owner
BIOL Biolase Inc 2017-12-04 10 percent owner
AWH Aspira Womens Health Inc 2013-05-13 10 percent owner
LIMIT LIMIT 2007-11-09 10 percent owner
LIMIT LIMIT 2004-02-02 10 percent owner

Oracle Investment Management Inc Latest Holdings Summary

Oracle Investment Management Inc currently owns a total of 1 stock. Oracle Investment Management Inc owns 34,743 shares of Accelerated Pharma Inc (ACCP) as of November 9, 2007, with a value of $0.

Latest Holdings of Oracle Investment Management Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACCP Accelerated Pharma Inc 2007-11-09 34,743 0.00 0

Holding Weightings of Oracle Investment Management Inc


Oracle Investment Management Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Oracle Investment Management Inc has made a total of 0 transactions in Accelerated Pharma Inc (ACCP) over the past 5 years. The most-recent trade in Accelerated Pharma Inc is the sale of 0 shares on November 9, 2007, which brought Oracle Investment Management Inc around $0.

Insider Trading History of Oracle Investment Management Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Oracle Investment Management Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Oracle Investment Management Inc Ownership Network

Ownership Network List of Oracle Investment Management Inc

No Data

Ownership Network Relation of Oracle Investment Management Inc

Insider Network Chart

Oracle Investment Management Inc Owned Company Details

What does Soleno Therapeutics Inc do?

Who are the key executives at Soleno Therapeutics Inc?

Oracle Investment Management Inc is the 10 percent owner of Soleno Therapeutics Inc. Other key executives at Soleno Therapeutics Inc include Chief Financial Officer James H Mackaness , See Remarks Patricia C Hirano , and See Remarks Kristen Yen .

Soleno Therapeutics Inc (SLNO) Insider Trades Summary

Over the past 18 months, Oracle Investment Management Inc made no insider transaction in Soleno Therapeutics Inc (SLNO). Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 457,740 shares made by Bhatnagar Anish , a net sale of 75,906 shares made by Kristen Yen , and a net sale of 44,382 shares made by Patricia C Hirano .

In summary, during the past 3 months, insiders sold 1,370,041 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 1,370,041 shares. During the past 18 months, 2,789,898 shares of Soleno Therapeutics Inc (SLNO) were sold and 1,210,087 shares were bought by its insiders, resulting in a net sale of 1,579,811 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Soleno Therapeutics Inc Insider Transactions

No Available Data

Oracle Investment Management Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Oracle Investment Management Inc. You might contact Oracle Investment Management Inc via mailing address: 177 W Putnam Avenue, Greenwich Ct 06830.

Discussions on Oracle Investment Management Inc

No discussions yet.